Anoro Ellipta (umeclidinium and vilanterol inhalation powder), for Oral Inhalation
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
February 2016
ADVERSE REACTIONS
Postmarketing Experience
In addition to adverse reactions reported from clinical trials,...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Clinical Trials | Drugs & Pharmacology